highly significantp < 0.0001
Post hoc paired t-tests confirmed highly significant improvements at 1, 3, and 6 months (all p < 0.0001).
Post hoc paired t-tests confirmed highly significant improvements at 1, 3, and 6 months (all p < 0.0001).
Clavien–Dindo IIIa complications were reported in 13.0% (3/23) of NOSE-LRR patients, with no events in the other two groups; this difference showed a trend but did not reach statistical significance ( p = 0.015).
Although a positive trend was observed over time, the main effect of time did not reach statistical significance (F(3,325) = 1.76, p = 0.1546).
Given a significant main effect of gender, WIS was analyzed separately for male and female patients, but subgroup analyses also failed to reach significance.
Clavien–Dindo IIIa complications were reported in 13.0% (3/23) of NOSE-LRR patients, with no events in the other two groups; this difference showed a trend but did not reach statistical significance ( p = 0.015).